Cargando…
HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction
BACKGROUND: This study aimed to investigate the role of histone deacetylase 5 (HDAC5) in ventricular remodeling and explore the therapeutic potential of the HDAC5 inhibitor LMK235. METHODS: A transverse aortic constriction (TAC) mouse model and angiotensin II (Ang II)-treated H9C2 cells were used to...
Autores principales: | Zhu, Chenxi, Piao, Zhehao, Jin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476361/ https://www.ncbi.nlm.nih.gov/pubmed/37667300 http://dx.doi.org/10.1186/s13023-023-02896-y |
Ejemplares similares
-
Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
por: Zhong, Peng, et al.
Publicado: (2023) -
Deletion of Microfibrillar‐Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure
por: Wang, Hui-bo, et al.
Publicado: (2020) -
Rad GTPase Deletion Attenuates Post-Ischemic Cardiac Dysfunction and Remodeling
por: Manning, Janet R., et al.
Publicado: (2018) -
Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1‐Wnt3a‐β‐Catenin Signaling Axis
por: Wang, Luyang, et al.
Publicado: (2023) -
Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway
por: Liu, Aiguo, et al.
Publicado: (2017)